{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:13:05Z","timestamp":1791238385552,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Human T cell lymphotropic virus type 1 (HTLV-1) infection can lead to development of adult T cell leukemia\/lymphoma (ATL) or HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in a subset of infected subjects. HTLV-1 basic leucine zipper factor (HBZ) gene has a critical role in HTLV-1 infectivity and the development of ATL and HAM\/TSP. However, little is known about the immune response against HBZ in HTLV-1-infected individuals. In this study, we examined antibody responses against HBZ in serum\/plasma samples from 436 subjects including HTLV-1 seronegative donors, asymptomatic carriers (AC), ATL, and HAM\/TSP patients using the luciferase immunoprecipitation system.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Immunoreactivity against HBZ was detected in subsets of all HTLV-1-infected individuals but the test did not discriminate between AC, ATL and HAM\/TSP. However, the frequency of detection of HBZ-specific antibodies in the serum of ATL patients with the chronic subtype was higher than in ATL patients with the lymphomatous subtype. Antibody responses against HBZ were also detected in cerebrospinal fluid of HAM\/TSP patients with anti-HBZ in serum. Antibody responses against HBZ did not correlate with proviral load and HBZ mRNA expression in HAM\/TSP patients, but the presence of an HBZ-specific response was associated with reduced CD4<jats:sup>+<\/jats:sup> T cell activation in HAM\/TSP patients. Moreover, HBZ-specific antibody inhibited lymphoproliferation in the PBMC of HAM\/TSP patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This is the first report demonstrating humoral immune response against HBZ associated with HTLV-I infection. Thus, a humoral immune response against HBZ might play a role in HTLV-1 infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-4690-10-19","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T09:14:43Z","timestamp":1360746883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals"],"prefix":"10.1186","volume":"10","author":[{"given":"Yoshimi","family":"Enose-Akahata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raya","family":"Massoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Bialuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kory R","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick L","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,13]]},"reference":[{"key":"3400_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E: Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis. 2007, 7: 266-281. 10.1016\/S1473-3099(07)70081-6.","journal-title":"Lancet Infect Dis"},{"key":"3400_CR2","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980, 77: 7415-7419. 10.1073\/pnas.77.12.7415.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3400_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985, 2: 407-410.","journal-title":"Lancet"},{"key":"3400_CR4","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986, 1: 1031-1032.","journal-title":"Lancet"},{"key":"3400_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00005072-199307000-00010","volume":"52","author":"F Umehara","year":"1993","unstructured":"Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Matsumuro K, Sato E, Osame M: Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1993, 52: 424-430. 10.1097\/00005072-199307000-00010.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3400_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1056\/NEJM199703203361205","volume":"336","author":"MC Levin","year":"1997","unstructured":"Levin MC, Lehky TJ, Flerlage AN, Katz D, Kingma DW, Jaffe ES, Heiss JD, Patronas N, McFarland HF, Jacobson S: Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. N Engl J Med. 1997, 336: 839-845. 10.1056\/NEJM199703203361205.","journal-title":"N Engl J Med"},{"key":"3400_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/348245a0","volume":"348","author":"S Jacobson","year":"1990","unstructured":"Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S: Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990, 348: 245-248. 10.1038\/348245a0.","journal-title":"Nature"},{"key":"3400_CR8","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.1073\/pnas.95.13.7568","volume":"95","author":"TF Greten","year":"1998","unstructured":"Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S, Schneck JP: Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM\/TSP patients. Proc Natl Acad Sci USA. 1998, 95: 7568-7573. 10.1073\/pnas.95.13.7568.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3400_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/ana.10065","volume":"50","author":"M Nagai","year":"2001","unstructured":"Nagai M, Yamano Y, Brennan MB, Mora CA, Jacobson S: Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM\/TSP. Ann Neurol. 2001, 50: 807-812. 10.1002\/ana.10065.","journal-title":"Ann Neurol"},{"key":"3400_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/BF00868998","volume":"243","author":"B Kitze","year":"1996","unstructured":"Kitze B, Usuku K, Izumo S, Nakamura M, Shiraki H, Ijichi S, Yashiki S, Fujiyoshi T, Sonoda S, Osame M: Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy. J Neurol. 1996, 243: 393-400. 10.1007\/BF00868998.","journal-title":"J Neurol"},{"key":"3400_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s11481-010-9216-9","volume":"5","author":"E Matsuura","year":"2010","unstructured":"Matsuura E, Yamano Y, Jacobson S: Neuroimmunity of HTLV-I Infection. J Neuroimmune Pharmacol. 2010, 5: 310-325. 10.1007\/s11481-010-9216-9.","journal-title":"J Neuroimmune Pharmacol"},{"key":"3400_CR12","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M: Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol. 1998, 4: 586-593. 10.3109\/13550289809114225.","journal-title":"J Neurovirol"},{"key":"3400_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0092-8674(87)90754-9","volume":"49","author":"SL Cross","year":"1987","unstructured":"Cross SL, Feinberg MB, Wolf JB, Holbrook NJ, Wong-Staal F, Leonard WJ: Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell. 1987, 49: 47-56. 10.1016\/0092-8674(87)90754-9.","journal-title":"Cell"},{"key":"3400_CR14","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1073\/pnas.84.15.5389","volume":"84","author":"M Siekevitz","year":"1987","unstructured":"Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F, Greene WC: Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc Natl Acad Sci USA. 1987, 84: 5389-5393. 10.1073\/pnas.84.15.5389.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3400_CR15","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1073\/pnas.95.5.2452","volume":"95","author":"N Azimi","year":"1998","unstructured":"Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA: Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc Natl Acad Sci USA. 1998, 95: 2452-2457. 10.1073\/pnas.95.5.2452.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3400_CR16","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.4049\/jimmunol.166.4.2602","volume":"166","author":"JM Mariner","year":"2001","unstructured":"Mariner JM, Lantz V, Waldmann TA, Azimi N: Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site. J Immunol. 2001, 166: 2602-2609.","journal-title":"J Immunol"},{"key":"3400_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/blood.V99.1.88","volume":"99","author":"Y Yamano","year":"2002","unstructured":"Yamano Y, Nagai M, Brennan M, Mora CA, Soldan SS, Tomaru U, Takenouchi N, Izumo S, Osame M, Jacobson S: Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM\/TSP). Blood. 2002, 99: 88-94. 10.1182\/blood.V99.1.88.","journal-title":"Blood"},{"key":"3400_CR18","doi-asserted-by":"publisher","first-page":"12813","DOI":"10.1128\/JVI.76.24.12813-12822.2002","volume":"76","author":"G Gaudray","year":"2002","unstructured":"Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM: The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol. 2002, 76: 12813-12822. 10.1128\/JVI.76.24.12813-12822.2002.","journal-title":"J Virol"},{"key":"3400_CR19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1073\/pnas.0507631103","volume":"103","author":"Y Satou","year":"2006","unstructured":"Satou Y, Yasunaga J, Yoshida M, Matsuoka M: HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci USA. 2006, 103: 720-725. 10.1073\/pnas.0507631103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3400_CR20","doi-asserted-by":"publisher","first-page":"43620","DOI":"10.1074\/jbc.M307275200","volume":"278","author":"J Basbous","year":"2003","unstructured":"Basbous J, Arpin C, Gaudray G, Piechaczyk M, Devaux C, Mesnard JM: The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem. 2003, 278: 43620-43627. 10.1074\/jbc.M307275200.","journal-title":"J Biol Chem"},{"key":"3400_CR21","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/sj.onc.1208297","volume":"24","author":"J Matsumoto","year":"2005","unstructured":"Matsumoto J, Ohshima T, Isono O, Shimotohno K: HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene. 2005, 24: 1001-1010. 10.1038\/sj.onc.1208297.","journal-title":"Oncogene"},{"key":"3400_CR22","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1128\/JVI.00480-06","volume":"81","author":"I Lemasson","year":"2007","unstructured":"Lemasson I, Lewis MR, Polakowski N, Hivin P, Cavanagh MH, Thebault S, Barbeau B, Nyborg JK, Mesnard JM: Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol. 2007, 81: 1543-1553. 10.1128\/JVI.00480-06.","journal-title":"J Virol"},{"key":"3400_CR23","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/blood-2008-06-161729","volume":"113","author":"T Zhao","year":"2009","unstructured":"Zhao T, Yasunaga J, Satou Y, Nakao M, Takahashi M, Fujii M, Matsuoka M: Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB. Blood. 2009, 113: 2755-2764. 10.1182\/blood-2008-06-161729.","journal-title":"Blood"},{"key":"3400_CR24","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1182\/blood-2005-11-4551","volume":"107","author":"J Arnold","year":"2006","unstructured":"Arnold J, Yamamoto B, Li M, Phipps AJ, Younis I, Lairmore MD, Green PL: Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood. 2006, 107: 3976-3982. 10.1182\/blood-2005-11-4551.","journal-title":"Blood"},{"key":"3400_CR25","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","volume":"112","author":"J Arnold","year":"2008","unstructured":"Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL: Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood. 2008, 112: 3788-3797. 10.1182\/blood-2008-04-154286.","journal-title":"Blood"},{"key":"3400_CR26","doi-asserted-by":"publisher","first-page":"e1001274","DOI":"10.1371\/journal.ppat.1001274","volume":"7","author":"Y Satou","year":"2011","unstructured":"Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N, et al: HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011, 7: e1001274-10.1371\/journal.ppat.1001274.","journal-title":"PLoS Pathog"},{"key":"3400_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-6-19","volume":"6","author":"M Saito","year":"2009","unstructured":"Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y: In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Retrovirology. 2009, 6: 19-10.1186\/1742-4690-6-19.","journal-title":"Retrovirology"},{"key":"3400_CR28","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1099\/vir.0.010199-0","volume":"90","author":"K Suemori","year":"2009","unstructured":"Suemori K, Fujiwara H, Ochi T, Ogawa T, Matsuoka M, Matsumoto T, Mesnard JM, Yasukawa M: HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. J Gen Virol. 2009, 90: 1806-1811. 10.1099\/vir.0.010199-0.","journal-title":"J Gen Virol"},{"key":"3400_CR29","doi-asserted-by":"publisher","first-page":"e1001117","DOI":"10.1371\/journal.ppat.1001117","volume":"6","author":"A Macnamara","year":"2010","unstructured":"Macnamara A, Rowan A, Hilburn S, Kadolsky U, Fujiwara H, Suemori K, Yasukawa M, Taylor G, Bangham CR, Asquith B: HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog. 2010, 6: e1001117-10.1371\/journal.ppat.1001117.","journal-title":"PLoS Pathog"},{"key":"3400_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1742-4690-5-96","volume":"5","author":"PD Burbelo","year":"2008","unstructured":"Burbelo PD, Meoli E, Leahy HP, Graham J, Yao K, Oh U, Janik JE, Mahieux R, Kashanchi F, Iadarola MJ, Jacobson S: Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Retrovirology. 2008, 5: 96-10.1186\/1742-4690-5-96.","journal-title":"Retrovirology"},{"key":"3400_CR31","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1182\/blood-2011-11-390807","volume":"119","author":"Y Enose-Akahata","year":"2012","unstructured":"Enose-Akahata Y, Abrams A, Johnson KR, Maloney EM, Jacobson S: Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers, ATL, and HAM\/TSP patients from Jamaica. Blood. 2012, 119: 2829-2836. 10.1182\/blood-2011-11-390807.","journal-title":"Blood"},{"key":"3400_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ana.410210203","volume":"21","author":"M Osame","year":"1987","unstructured":"Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, Igata A: Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol. 1987, 21: 117-122. 10.1002\/ana.410210203.","journal-title":"Ann Neurol"},{"key":"3400_CR33","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20032042","volume":"199","author":"Y Yamano","year":"2004","unstructured":"Yamano Y, Cohen CJ, Takenouchi N, Yao K, Tomaru U, Li HC, Reiter Y, Jacobson S: Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease. J Exp Med. 2004, 199: 1367-1377. 10.1084\/jem.20032042.","journal-title":"J Exp Med"},{"key":"3400_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1742-4690-5-34","volume":"5","author":"T Usui","year":"2008","unstructured":"Usui T, Yanagihara K, Tsukasaki K, Murata K, Hasegawa H, Yamada Y, Kamihira S: Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells. Retrovirology. 2008, 5: 34-10.1186\/1742-4690-5-34.","journal-title":"Retrovirology"},{"key":"3400_CR35","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1349-7006.2011.01862.x","volume":"102","author":"M Kannagi","year":"2011","unstructured":"Kannagi M, Hasegawa A, Kinpara S, Shimizu Y, Takamori A, Utsunomiya A: Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity. Cancer Sci. 2011, 102: 670-676. 10.1111\/j.1349-7006.2011.01862.x.","journal-title":"Cancer Sci"},{"issue":"Suppl 1","key":"3400_CR36","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/00042560-199600001-00005","volume":"13","author":"B Hanchard","year":"1996","unstructured":"Hanchard B: Adult T-cell leukemia\/lymphoma in Jamaica: 1986\u20131995. J Acquir Immune Defic Syndr Hum Retrovirol. 1996, 13 (Suppl 1): S20-25.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"3400_CR37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M: Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387). Br J Haematol. 1991, 79: 428-437. 10.1111\/j.1365-2141.1991.tb08051.x.","journal-title":"Br J Haematol"},{"key":"3400_CR38","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1182\/blood-2010-11-316463","volume":"117","author":"F Rende","year":"2011","unstructured":"Rende F, Cavallari I, Corradin A, Silic-Benussi M, Toulza F, Toffolo GM, Tanaka Y, Jacobson S, Taylor GP, D\u2019Agostino DM, et al: Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. Blood. 2011, 117: 4855-4859. 10.1182\/blood-2010-11-316463.","journal-title":"Blood"},{"key":"3400_CR39","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1128\/JVI.80.5.2495-2505.2006","volume":"80","author":"K Murata","year":"2006","unstructured":"Murata K, Hayashibara T, Sugahara K, Uemura A, Yamaguchi T, Harasawa H, Hasegawa H, Tsuruda K, Okazaki T, Koji T, et al: A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J Virol. 2006, 80: 2495-2505. 10.1128\/JVI.80.5.2495-2505.2006.","journal-title":"J Virol"},{"key":"3400_CR40","doi-asserted-by":"publisher","first-page":"28837","DOI":"10.1074\/jbc.274.41.28837","volume":"274","author":"KT Jeang","year":"1999","unstructured":"Jeang KT, Xiao H, Rich EA: Multifaceted activities of the HIV-1 transactivator of transcription. Tat. J Biol Chem. 1999, 274: 28837-28840. 10.1074\/jbc.274.41.28837.","journal-title":"Tat. J Biol Chem"},{"key":"3400_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jmv.1890260306","volume":"26","author":"WJ Krone","year":"1988","unstructured":"Krone WJ, Debouck C, Epstein LG, Heutink P, Meloen R, Goudsmit J: Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo. J Med Virol. 1988, 26: 261-270. 10.1002\/jmv.1890260306.","journal-title":"J Med Virol"},{"issue":"Suppl","key":"3400_CR42","doi-asserted-by":"publisher","first-page":"S188","DOI":"10.1002\/ana.410230742","volume":"23","author":"M Ceroni","year":"1988","unstructured":"Ceroni M, Piccardo P, Rodgers-Johnson P, Mora C, Asher DM, Gajdusek DC, Gibbs CJ: Intrathecal synthesis of IgG antibodies to HTLV-I supports an etiological role for HTLV-I in tropical spastic paraparesis. Ann Neurol. 1988, 23 (Suppl): S188-191.","journal-title":"Ann Neurol"},{"key":"3400_CR43","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/infdis\/157.6.1226","volume":"157","author":"A Gessain","year":"1988","unstructured":"Gessain A, Caudie C, Gout O, Vernant JC, Maurs L, Giordano C, Malone G, Tournier-Lasserve E, Essex M, De-The G: Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis. J Infect Dis. 1988, 157: 1226-1234. 10.1093\/infdis\/157.6.1226.","journal-title":"J Infect Dis"},{"key":"3400_CR44","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ana.410240606","volume":"24","author":"LM Grimaldi","year":"1988","unstructured":"Grimaldi LM, Roos RP, Devare SG, Casey JM, Maruo Y, Hamada T, Tashiro K: HTLV-I-associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody. Ann Neurol. 1988, 24: 727-731. 10.1002\/ana.410240606.","journal-title":"Ann Neurol"},{"key":"3400_CR45","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1212\/WNL.39.12.1566","volume":"39","author":"H Link","year":"1989","unstructured":"Link H, Cruz M, Gessain A, Gout O, de The G, Kam-Hansen S: Chronic progressive myelopathy associated with HTLV-I: oligoclonal IgG and anti-HTLV-I IgG antibodies in cerebrospinal fluid and serum. Neurology. 1989, 39: 1566-1572. 10.1212\/WNL.39.12.1566.","journal-title":"Neurology"},{"key":"3400_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1212\/01.wnl.0000251300.24540.c4","volume":"68","author":"M Puccioni-Sohler","year":"2007","unstructured":"Puccioni-Sohler M, Yamano Y, Rios M, Carvalho SM, Vasconcelos CC, Papais-Alvarenga R, Jacobson S: Differentiation of HAM\/TSP from patients with multiple sclerosis infected with HTLV-I. Neurology. 2007, 68: 206-213. 10.1212\/01.wnl.0000251300.24540.c4.","journal-title":"Neurology"},{"key":"3400_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0022-1759(99)00137-4","volume":"231","author":"LL Green","year":"1999","unstructured":"Green LL: Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies. J Immunol Methods. 1999, 231: 11-23. 10.1016\/S0022-1759(99)00137-4.","journal-title":"J Immunol Methods"},{"key":"3400_CR48","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/321522a0","volume":"321","author":"PT Jones","year":"1986","unstructured":"Jones PT, Dear PH, Foote J, Neuberger MS, Winter G: Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature. 1986, 321: 522-525. 10.1038\/321522a0.","journal-title":"Nature"},{"key":"3400_CR49","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/348552a0","volume":"348","author":"J McCafferty","year":"1990","unstructured":"McCafferty J, Griffiths AD, Winter G, Chiswell DJ: Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 1990, 348: 552-554. 10.1038\/348552a0.","journal-title":"Nature"},{"key":"3400_CR50","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nm.1966","volume":"15","author":"A Jin","year":"2009","unstructured":"Jin A, Ozawa T, Tajiri K, Obata T, Kondo S, Kinoshita K, Kadowaki S, Takahashi K, Sugiyama T, Kishi H, Muraguchi A: A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood. Nat Med. 2009, 15: 1088-1092. 10.1038\/nm.1966.","journal-title":"Nat Med"},{"key":"3400_CR51","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nature07930","volume":"458","author":"JF Scheid","year":"2009","unstructured":"Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, Pietzsch J, Ott RG, Anthony RM, Zebroski H, Hurley A, et al: Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature. 2009, 458: 636-640. 10.1038\/nature07930.","journal-title":"Nature"},{"key":"3400_CR52","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm1080","volume":"10","author":"E Traggiai","year":"2004","unstructured":"Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, Murphy BR, Rappuoli R, Lanzavecchia A: An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med. 2004, 10: 871-875. 10.1038\/nm1080.","journal-title":"Nat Med"},{"key":"3400_CR53","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1182\/blood.V98.6.1858","volume":"98","author":"M Nagai","year":"2001","unstructured":"Nagai M, Brennan MB, Sakai JA, Mora CA, Jacobson S: CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood. 2001, 98: 1858-1861. 10.1182\/blood.V98.6.1858.","journal-title":"Blood"},{"key":"3400_CR54","doi-asserted-by":"publisher","first-page":"19985","DOI":"10.1073\/pnas.1014074107","volume":"107","author":"DL Mallery","year":"2010","unstructured":"Mallery DL, McEwan WA, Bidgood SR, Towers GJ, Johnson CM, James LC: Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci USA. 2010, 107: 19985-19990. 10.1073\/pnas.1014074107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3400_CR55","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/ije\/25.5.1083","volume":"25","author":"EL Murphy","year":"1996","unstructured":"Murphy EL, Wilks R, Hanchard B, Cranston B, Figueroa JP, Gibbs WN, Murphy J, Blattner WA: A case\u2013control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in Jamaica. Int J Epidemiol. 1996, 25: 1083-1089. 10.1093\/ije\/25.5.1083.","journal-title":"Int J Epidemiol"},{"key":"3400_CR56","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/oxfordjournals.aje.a115824","volume":"133","author":"EL Murphy","year":"1991","unstructured":"Murphy EL, Figueroa JP, Gibbs WN, Holding-Cobham M, Cranston B, Malley K, Bodner AJ, Alexander SS, Blattner WA: Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol. 1991, 133: 1114-1124.","journal-title":"Am J Epidemiol"},{"key":"3400_CR57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00042560-199802010-00011","volume":"17","author":"EM Maloney","year":"1998","unstructured":"Maloney EM, Cleghorn FR, Morgan OS, Rodgers-Johnson P, Cranston B, Jack N, Blattner WA, Bartholomew C, Manns A: Incidence of HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica and Trinidad. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 17: 167-170. 10.1097\/00042560-199802010-00011.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"3400_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1086\/317932","volume":"183","author":"M Nagai","year":"2001","unstructured":"Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, Jacobson S: Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis: correlation with HTLV-I provirus load. J Infect Dis. 2001, 183: 197-205. 10.1086\/317932.","journal-title":"J Infect Dis"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-10-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:19:13Z","timestamp":1630534753000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-10-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,13]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3400"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-10-19","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,13]]},"assertion":[{"value":"28 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"19"}}